SK bioscience Co.,Ltd.

KRX:302440.KS

47750 (KRW) • At close June 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

2024202320222021202020192018
Revenue 267,545.049369,505.556456,725.871929,000.93225,610.785183,937.70288,173.588
Cost of Revenue 236,569.373227,681.203217,114.93358,717.803130,268.716106,078.00548,958.069
Gross Profit 30,975.676141,824.353239,610.941570,283.12795,342.06977,859.69739,215.519
Gross Profit Ratio 0.1160.3840.5250.6140.4230.4230.445
Reseach & Development Expenses 71,352.81485,743.41657,959.64547,250.07525,987.127,719.66310,512.411
General & Administrative Expenses 8,690.8676,964.6085,618.6484,167.3642,371.8322,393.6081,123.199
Selling & Marketing Expenses 32,207.20518,382.89821,698.47711,571.72610,458.56710,966.6355,914.201
SG&A 40,898.07260,811.92527,317.12515,739.0912,830.39913,360.2437,037.4
Other Expenses 57,156.088039,320.55433,074.10618,814.12213,983.272-480.806
Operating Expenses 169,406.974146,555.341124,597.32496,063.27157,631.62155,063.17824,008.862
Operating Income -138,431.298-4,730.988115,013.618474,219.85637,710.44722,796.51915,206.658
Operating Income Ratio -0.517-0.0130.2520.510.1670.1240.172
Total Other Income Expenses Net 49,324.4712,058.21526,719.564-3,091.676-417.194-4,311.247-14,342.668
Income Before Tax -89,106.8287,327.227141,733.182471,128.18137,293.25318,485.273863.99
Income Before Tax Ratio -0.3330.020.310.5070.1650.10.01
Income Tax Expense -38,989.758-14,990.49219,281.233115,988.9044,403.5413,807.868443.146
Net Income -53,881.19922,317.719122,451.95355,139.27732,889.71214,677.405420.845
Net Income Ratio -0.2010.060.2680.3820.1460.080.005
EPS -700.162911,596.184,642.34429.93191.86209.93
EPS Diluted -701.32289.791,589.844,642.34429.93191.86209.93
EBITDA -36,196.68443,490.069142,250.027492,995.16157,971.38437,213.07321,109.42
EBITDA Ratio -0.1350.1180.3110.5310.2570.2020.239